Ke-Wang Luo

1.1k total citations
29 papers, 918 citations indexed

About

Ke-Wang Luo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ke-Wang Luo has authored 29 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Ke-Wang Luo's work include Tea Polyphenols and Effects (6 papers), Bone health and treatments (5 papers) and Immune Cell Function and Interaction (4 papers). Ke-Wang Luo is often cited by papers focused on Tea Polyphenols and Effects (6 papers), Bone health and treatments (5 papers) and Immune Cell Function and Interaction (4 papers). Ke-Wang Luo collaborates with scholars based in China, Hong Kong and Australia. Ke-Wang Luo's co-authors include Kwok‐Pui Fung, Shihua Wu, Lu Yang, Weiren Huang, Bao‐Hui Cheng, Feiyan Liu, Jianguo Sun, Judy Yuet‐Wa Chan, Grace Gar‐Lee Yue and Chun‐Hay Ko and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Molecules.

In The Last Decade

Ke-Wang Luo

27 papers receiving 901 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ke-Wang Luo 397 204 199 149 129 29 918
Youn Kyung Choi 440 1.1× 152 0.7× 157 0.8× 73 0.5× 105 0.8× 36 957
Ming‐Der Shi 357 0.9× 135 0.7× 144 0.7× 74 0.5× 157 1.2× 20 745
Hye‐Sook Seo 532 1.3× 201 1.0× 177 0.9× 90 0.6× 97 0.8× 27 936
Manzar Alam 597 1.5× 126 0.6× 225 1.1× 287 1.9× 156 1.2× 38 1.4k
Julia Kin-Ming Lee 366 0.9× 166 0.8× 140 0.7× 66 0.4× 93 0.7× 30 749
Brian Chi‐Yan Cheng 521 1.3× 138 0.7× 138 0.7× 60 0.4× 127 1.0× 28 972
Muobarak J. Tuorkey 386 1.0× 128 0.6× 91 0.5× 134 0.9× 136 1.1× 25 971
Ching-Huai Ko 470 1.2× 213 1.0× 143 0.7× 76 0.5× 222 1.7× 9 843
Jin Mo Ku 369 0.9× 166 0.8× 113 0.6× 60 0.4× 88 0.7× 36 805
Chung Ho Ryu 536 1.4× 140 0.7× 112 0.6× 112 0.8× 191 1.5× 32 1.0k

Countries citing papers authored by Ke-Wang Luo

Since Specialization
Citations

This map shows the geographic impact of Ke-Wang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke-Wang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke-Wang Luo more than expected).

Fields of papers citing papers by Ke-Wang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke-Wang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke-Wang Luo. The network helps show where Ke-Wang Luo may publish in the future.

Co-authorship network of co-authors of Ke-Wang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ke-Wang Luo. A scholar is included among the top collaborators of Ke-Wang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke-Wang Luo. Ke-Wang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Hanchao, Yikun Yao, Wenjun Hu, et al.. (2025). Caspase‐6/Gasdermin C‐Mediated Tumor Cell Pyroptosis Promotes Colorectal Cancer Progression Through CXCL2‐Dependent Recruitment of Myeloid‐Derived Suppressor Cells. Advanced Science. 12(20). e2411375–e2411375. 2 indexed citations
2.
3.
Luo, Ke-Wang, et al.. (2024). Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer. Pharmaceutics. 16(7). 865–865. 17 indexed citations
4.
Gao, Hanchao, Shi Xu, Wenjun Hu, et al.. (2024). Gasdermin D promotes development of intestinal tumors through regulating IL-1β release and gut microbiota composition. Cell Communication and Signaling. 22(1). 511–511. 2 indexed citations
5.
Li, Meiye, et al.. (2023). Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer. Pharmaceutics. 15(7). 1788–1788. 6 indexed citations
6.
Luo, Ke-Wang, et al.. (2020). EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway. Frontiers in Cell and Developmental Biology. 8. 606123–606123. 28 indexed citations
7.
Zhao, Yanli, David K. C. Cooper, Ying Lu, et al.. (2019). Isolation and Culture of Primary Aortic Endothelial Cells from Miniature Pigs. Journal of Visualized Experiments. 4 indexed citations
8.
Ko, Chun‐Hay, Grace Gar‐Lee Yue, Si Gao, et al.. (2017). Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model. Journal of Ethnopharmacology. 204. 77–85. 16 indexed citations
9.
Chen, Wei, Ke-Wang Luo, Shiyang He, et al.. (2017). TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling. Journal of Cancer. 8(10). 1892–1899. 21 indexed citations
10.
Luo, Ke-Wang, et al.. (2016). EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. The Journal of Nutritional Biochemistry. 41. 56–64. 112 indexed citations
11.
Luo, Ke-Wang, Grace Gar‐Lee Yue, Chun‐Hay Ko, et al.. (2015). The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis. Oncology Reports. 34(1). 477–487. 12 indexed citations
12.
Zinonos, Irene, Ke-Wang Luo, Agatha Labrinidis, et al.. (2014). Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology. 45(2). 532–540. 19 indexed citations
13.
Han, Xiaoqiang, Grace Gar‐Lee Yue, Rui-Qi Yue, et al.. (2014). Structure Elucidation and Immunomodulatory Activity of A Beta Glucan from the Fruiting Bodies of Ganoderma sinense. PLoS ONE. 9(7). e100380–e100380. 45 indexed citations
14.
Luo, Ke-Wang, Chun‐Hay Ko, Grace Gar‐Lee Yue, et al.. (2014). The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model. Journal of Cancer Research and Clinical Oncology. 141(6). 1025–1036. 10 indexed citations
15.
Luo, Ke-Wang, Chun‐Hay Ko, Grace Gar‐Lee Yue, et al.. (2014). Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. The Journal of Nutritional Biochemistry. 25(4). 395–403. 51 indexed citations
16.
Luo, Ke-Wang, Chun‐Hay Ko, Grace Gar‐Lee Yue, et al.. (2013). Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models. Cancer Letters. 339(1). 42–48. 13 indexed citations
17.
Sun, Jianguo, Ngai Na Co, Tsun Yee Tsang, et al.. (2012). Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-κB in R-HepG2 Cell Line. PLoS ONE. 7(8). e40720–e40720. 57 indexed citations
18.
Luo, Ke-Wang, Jianguo Sun, Judy Yuet‐Wa Chan, et al.. (2011). Anticancer Effects of Imperatorin Isolated from Angelica dahurica: Induction of Apoptosis in HepG2 Cells through both Death-Receptor- and Mitochondria-Mediated Pathways. Chemotherapy. 57(6). 449–459. 126 indexed citations
19.
Liu, Feiyan, Ke-Wang Luo, Zhiming Yu, et al.. (2009). Suillin from the mushroom Suillus placidus as potent apoptosis inducer in human hepatoma HepG2 cells. Chemico-Biological Interactions. 181(2). 168–174. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youn Kyung Choi Breakdown of academic impact, for papers by Ming‐Der Shi Breakdown of academic impact, for papers by Hye‐Sook Seo Breakdown of academic impact, for papers by Manzar Alam Breakdown of academic impact, for papers by Julia Kin-Ming Lee Breakdown of academic impact, for papers by Brian Chi‐Yan Cheng Breakdown of academic impact, for papers by Muobarak J. Tuorkey Breakdown of academic impact, for papers by Ching-Huai Ko Breakdown of academic impact, for papers by Jin Mo Ku Breakdown of academic impact, for papers by Chung Ho Ryu
Rankless by CCL
2026